Hypothermia and Frostbite

Published on 10/02/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1908 times

131 Hypothermia and Frostbite

Perspective

Accidental hypothermia is responsible for approximately 700 deaths per year in the United States.1 It primarily affects those least able to ward off the effects of cold weather: the very young, the very old, and the poor, disabled, pharmacologically inquisitive, environmentally adventurous, and mentally ill. Urban people are common victims. Hypothermia can occur in many latitudes, with episodes reported even in Florida.2 It occurs when a person’s ability to generate heat and remain warm is outstripped by the ambient temperature.

In the United States, frostbite is often a disease of the indigent, the intoxicated, the mentally ill, and winter outdoor recreation enthusiasts. For both frostbite and hypothermia the literature consists of primarily case reports, case series, and reviews.

Hypothermia

Presenting Signs and Symptoms

Patients with mild hypothermia are awake, occasionally drowsy, uncomfortable, and shivering. They simply need insulation (blanket), dry clothes, and food. They will recover completely and can be discharged when normothermic and feeling better.

Patients with moderate hypothermia are generally confused and lethargic, often have slurred speech, and are typically not shivering. They require more energetic rewarming measures, including heated blankets, resistive and hot air blankets (Bair Hugger), and close monitoring, including core temperature. Though strictly considered active internal rewarming, the use of heated, humidified oxygen and warmed intravenous (IV) fluids is reasonable in this situation. Patients whose hypothermia responds to these measures may be discharged when normothermic, awake, alert, and ambulatory. Patients with severe hypothermia require prompt intervention, close monitoring, and potentially aggressive, invasive rewarming therapies.

It is of the utmost importance to learn the circumstances that led to the patient becoming hypothermic. The possibility of a verify drug overdose, trauma, infection, drowning, or decompensated comorbid conditions—to name but a few examples—must be considered, sought, and treated along with the hypothermia.

The critical element of the diagnosis of hypothermia is accurate measurement of core temperature. Several methods exist, all of which have potential drawbacks (Table 131.3). Laboratory and physiologic changes are correlated with the temperature. For example, a normal hematocrit value in a severely hypothermic patient should prompt concern for hemorrhage because the hematocrit should rise in a predictable fashion with ever-lowering temperature. Alternatively, arterial blood gas values should be interpreted as though the patient is normothermic (the alpha-stat method) and not corrected for the actual core temperature (the pH-stat method). Evaluation for infection, metabolic derangement, and cardiac, neurologic, renal, and other organ system abnormalities is important because comorbid conditions are common as a cause, a consequence, or coincidence of hypothermia.

Table 131.3 Methods of Measuring Core Temperature

METHOD COMMENTS
Esophageal probe Easy to insert
Falsely high temperature readings possible with warmed oxygen via an endotracheal tube
Rectal probe Insert to 15-20 cm
If the probe is in or surrounded by cold stool, temperature recordings will lag behind true changes
Temperature-recording Foley catheter Inflowing cold urine may falsely lower temperature recordings
Pulmonary artery catheter Most accurate and most invasive method
Higher potential for iatrogenic injury, especially ventricular fibrillation in cold, irritable myocardium

Treatment

Severe Hypothermia

Active internal rewarming is needed for patients with moderate and severe hypothermia. Actions are directed toward heating the core preferentially over the periphery. This goal is accomplished via methods of variable invasiveness and complexity, as follows:

Heated, humidified oxygen (40° C to 45° C) administered via face mask or endotracheal tube; it primarily serves to prevent additional heat loss.

Administration of heated IV fluids (40° C to 42° C) adds negligible heat overall but does aid in preventing further heat loss.

Gastric or bladder lavage (or both) via nasogastric tube and Foley catheter is relatively easily accomplished; however, the small volume of these cavities limits the effectiveness of these modalities.

Peritoneal lavage with prepackaged dialysate or standard crystalloid fluids heated to about 45° C. This method is quicker if two catheters, one for afferent flow and one for efferent flow, are used. Rewarming rates average 2° C to 3° C per hour.3,4

Closed thoracic cavity lavage (pleural lavage) of the left hemithorax is done with two 36-French thoracostomy tubes and isotonic fluid heated to about 42° C. Large volumes are required. The afferent tube is placed in the second intercostal space (ICS) in the midclavicular line. The efferent tube is placed in the usual location, the fourth or fifth ICS in the midaxillary line. Fluid is literally poured in by hand, infused with a large (60-mL) syringe, or administered directly with a rapid infuser (the hub of the rapid infuser fits snugly into the bore of a 36-French chest tube). Rewarming rates average about 3° C per hour.5,6

Left thoracotomy with mediastinal irrigation and internal cardiac massage is quite invasive with high attendant morbidity. It is very effective and self-explanatory and has rewarming rates as high as 5° C to 6° C per hour.7,8

Cardiopulmonary bypass (CPB) is the definitive method for rewarming. It is rapid, with rewarming rates of 9° C per hour or higher achieved, and supports blood pressure; however, CPB also requires specialized equipment and personnel that are not readily available in most hospitals.9,10

The use of medications, particularly cardioactive medications and vasopressors, is theoretically unappealing and thought to be potentially dangerous in a patient with a core temperature lower than 30° C, primarily because of decreased metabolism, which can lead to toxic levels. Similarly, defibrillation is less likely to be effective at temperatures lower than 30° C. However, citing the solely theoretic basis of these concerns, the 2010 American Heart Association guidelines now state that in patients with persistent ventricular fibrillation or tachycardia after a single shock it may be “reasonable to perform further defibrillation attempts according to the standard BLS [basic life support] algorithm concurrent with rewarming strategies.” Furthermore, regarding medication administration “it may be reasonable to consider administration of a vasopressor during cardiac arrest according to the standard ACLS [advanced cardiac life support] algorithm concurrent with rewarming strategies.”11 It is clear that very little is known about the utility of defibrillation and administration of vasoactive medications in patients with hypothermic cardiac arrest. Providers will have to decide each case on an individual basis and be guided by any response to the therapy used.

The phenomenon of core temperature afterdrop refers to the observation that a patient’s temperature can fall after rewarming efforts have begun. It is believed to be due to a combination of temperature equilibration and return of cold blood from the periphery to the patient’s core as perfusion is restored and strengthened. The clinical importance of core temperature afterdrop is keenly contested, and no consistent recommendations can be made regarding it. Certainly, attempts to rapidly rewarm a patient should not be delayed for fear of this consequence.

Next Steps in Care

Patients with mild hypothermia and (most) patients with moderate hypothermia can be treated in the emergency department and released when normothermic. This statement relies on the assumption that no other complicating social or medical problems are present that must be addressed. All patients with severe hypothermia should be admitted to the hospital, usually to an intensive care unit. Successful revival of these patients will require considerable time and resources.

Clear, universally accepted criteria on declaration of death in hypothermic patients are lacking, beyond the obvious recommendations regarding terminal injuries, rigidity that precludes chest compressions, and physical blockage of the mouth or nose by ice.

Numerous case reports have described neurologically intact survival after prolonged, severe hypothermia with cardiac arrest.7,12 A serum potassium level higher than 10 mmol/L has been postulated to be a marker of irreversible cell and therefore patient death13; however, another case report has called this approach into question.14 Pronouncement of death in a severely hypothermic patient should be made with reluctance until the patient’s core temperature has been warmed to higher than 30° C to 32° C and signs of life remain absent.

A reasonable approach to the hypothermic patient is presented in Figure 131.2.

image

Fig. 131.2 Algorithmic approach to patients with hypothermia.

ACLS, Advanced cardiac life support; CPR, cardiopulmonary resuscitation; PEA, pulseless electrical activity; VFib, ventricular fibrillation.

(From EB Medicine, publisher of EM Critical Care and Emergency Medicine Practice: Mulcahy AR, Watts MR. Accidental hypothermia: an evidence-based approach. Emerg Med Prac 2009;11:1–24. Available at www.ebmedicine.net.)

see Figure 131.2, Algorithmic Approach to Patiens with Hypothermia, online at www.expertconsult.com

Frostbite

Pathophysiology

Frostbite is a freezing injury to tissues. During this process it is believed that deposits of ice crystals causing interstitial, cellular, and vascular endothelial cell damage are one part of the pathophysiologic process.15 The vascular endothelial damage results in activation of the clotting cascade with resulting thrombosis, which leads to hypoperfusion, ischemia, and eventually tissue necrosis. The prominence of the clotting that can cause vascular occlusion can be seen on angiography and is the basis for the concept of treating selected patients with thrombolysis.

Treatment

Frostbite is a clinical diagnosis. Other cold-related tissue injuries to be considered are frostnip, pernio (chilblains), and trench foot. These injuries, however, are nonfreezing ones, in contrast to frostbite.

For a concise summation of nonfreezing injuries, see www.expertconsult.com

Hospital Management

Once the patient is in the hospital, the mainstay of treatment is rapid rewarming with a circulating bath of water heated to 40° C to 42° C for 10 to 30 minutes until the involved area is erythematous and pliable. Because rewarming is extraordinarily painful, liberal use of parenteral analgesics is usually necessary. Clear, large blisters should generally be débrided, but hemorrhagic ones should be left intact (their presence implies much deeper damage, and desiccation of the area is a concern). Débridement removes fluid that is rich in thromboxanes and prostaglandins, which are thought to be destructive to tissue. Aloe vera may be applied topically every 6 hours and the wounds bandaged.

Prophylactic antibiotics are controversial. Penicillin G has been advocated. Additionally, ibuprofen, 400 mg by mouth twice daily, is recommended in an attempt to interrupt the arachidonic acid cascade.15,16 Both catheter-directed intraarterial and systemic thrombolytic therapies have been used with impressive success in preventing amputations (Figs. 131.4 and 131.5). This novel therapy holds considerable promise but does have several limitations, including restriction to patients initially seen within 24 hours of the injury and risk for bleeding.17,18

image

Fig. 131.5 Angiogram of the foot shown in Figure. 131.3 after approximately 30 hours of tissue plasminogen activator infusion showing restoration of perfusion.

An amputation was averted with this therapy.

Most recently, a small, randomized trial of frostbite therapies showed remarkable success with intravenous iloprost, a prostacyclin (no digit amputations), over an IV nonsteroidal antiinflammatory drug (≈40% digit amputation rate) or recombinant tissue plasminogen activator plus iloprost (≈3% digit amputation rate).19 Whether this promising success can be repeated and confirmed elsewhere remains to be seen.

Early surgical management is not indicated for frostbite because of the difficulty of ascertaining the full extent of the tissue damage initially. Typically, the affected area is left to mummify and essentially autoamputate before the formal procedure is carried out. Some newer imaging modalities, such as nuclear scanning and magnetic resonance angiography, may be able to shorten the time to definitive surgery by delineating viable tissue earlier than possible with simple observation.

References

1 Centers for Disease Control and Prevention (CDC). Hypothermia-related deaths—Utah, 2000, and United States, 1979–1998. MMWR Morb Mortal Wkly Rep. 2002;51(4):76–78.

2 Danzl DF, Pozos RS, Auerbach PS, et al. Multicenter hypothermia survey. Ann Emerg Med. 1987;16:1042–1055.

3 Troelsen S, Rybro L, Knudsen F. Profound accidental hypothermia treated with peritoneal dialysis. Scand J Urol Nephrol. 1986;20:221–224.

4 Pickering BG, Bristow GK, Craig DB. Case history number 97: core rewarming by peritoneal irrigation in accidental hypothermia with cardiac arrest. Anesth Analg. 1977;56:574–577.

5 Hall KN, Syverud SA. Closed thoracic cavity lavage in the treatment of severe hypothermia in human beings. Ann Emerg Med. 1990;19:204–206.

6 Winegard C. Successful treatment of severe hypothermia and prolonged cardiac arrest with closed thoracic cavity lavage. J Emerg Med. 1997;15:629–632.

7 Brunette DD, Biros M, Mlinek EJ, et al. Internal cardiac massage and mediastinal irrigation in hypothermic cardiac arrest. Am J Emerg Med. 1992;10:32–34.

8 Brunette DD, McVaney K. Hypothermic cardiac arrest: an 11 year review of ED management and outcome. Am J Emerg Med. 2000;18:418–422.

9 Walpoth BH, Locher T, Leupi F, et al. Accidental deep hypothermia with cardiopulmonary arrest: extracorporeal blood rewarming in 11 patients. Eur J Cardiothorac Surg. 1990;4:390–393.

10 Walpoth BH, Walpoth-Aslan BN, Mattle HP, et al. Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood warming. N Engl J Med. 1997;337:1500–1505.

11 Vanden Hoek TL, Morrison LJ, Shuster M, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S829–S861.

12 Hauty MG, Esrig BC, Hill JG, et al. Prognostic factors in severe accidental hypothermia: experience from the Mt. Hood tragedy. J Trauma. 1987;27:1107–1112.

13 Schaller MD, Perret CH. Hyperkalemia: a prognostic factor during severe hypothermia. JAMA. 1990;264:1842–1845.

14 Dobson JA, Burgess JJ. Resuscitation of severe hypothermia by extracorporeal rewarming in a child. J Trauma. 1996;40:483–485.

15 Murphy JV, Banwell PE, Roberts AH, et al. Frostbite: pathogenesis and treatment. J Trauma. 2000;48:171–178.

16 McCauley RL, Hing DN, Robson MC, et al. Frostbite injuries: a rational approach based on the pathophysiology. J Trauma. 1983;23:143–147.

17 Twomey JA, Peltier G, Zera RT. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma. 2005;59:1350–1354. discussion 1354–5

18 Bruen KJ, Ballard JR, Morris SE, et al. Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy. Arch Surg. 2007;142:546–551. discussion 551–553

19 Cauchy E, Cheguillaume B, Chetaille E. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. N Engl J Med. 2011;364:189–190.